EXoPERT Joins Johnson & Johnson’s JLABS TMC to Advance AI Cancer Diagnostics
EXoPERT has joined Johnson & Johnson’s global incubator network, JLABS TMC, to accelerate development of its AI-enhanced exosome-based liquid biopsy platform for early cancer detection.